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Abstract
Background: Obtaining prospective written consent from women to participate in trials when they are
experiencing an obstetric emergency is challenging. Alternative consent pathways, such as gaining verbal consent
at enrolment followed, later, by obtaining written consent, have been advocated by some clinicians and bioethicists
but have received little empirical attention. We explored women’s and staff views about the consent procedures used
during the internal pilot of a trial (GOT-IT), where the protocol permitted staff to gain verbal consent at recruitment.
Methods: Interviews with staff (n = 27) and participating women (n = 22). Data were analysed thematically and
interviews were cross-compared to identify differences and similarities in participants’ views about the consent
procedures used.
Results: Women and some staff highlighted benefits to obtaining verbal consent at trial enrolment, including
expediting recruitment and reducing the burden on those left exhausted by their births. However, most staff with
direct responsibility for taking consent expressed extreme reluctance to proceed with enrolment until they had
obtained written consent, despite being comfortable using verbal procedures in their clinical practice. To account for
this resistance, staff drew a strong distinction between research and clinical care and suggested that a higher level of
consent was needed when recruiting into trials. In doing so, staff emphasised the need to engage women in reflexive
decision-making and highlighted the role that completing the consent form could play in enabling and evidencing
this process. While most staff cited their ethical responsibilities to women, they also voiced concerns that the absence
of a signed consent form at recruitment could expose them to greater risk of litigation were an individual to
experience a complication during the trial. Inexperience of recruiting into peripartum trials and limited availability of
staff trained to take consent also reinforced preferences for obtaining written consent at recruitment.
Conclusions: While alternative consent pathways have an important role to play in advancing emergency medicine
research, and may be appreciated by potential recruits, they may give rise to unintended ethical and logistical
challenges for staff. Staff would benefit from training and support to increase their confidence and willingness to
recruit into trials using alternative consent pathways.
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Background
The challenges of recruiting and gaining consent to
participate in clinical trials are well recognised, especially
when the research is undertaken in emergency situations
or in particular patient groups such as pregnant or
recently pregnant women [1–3]. This is because the
ability of the person to make an informed decision may
be partly or severely compromised [4, 5]. There may also
be very limited time in which to undertake recruitment,
and/or recruiting staff may feel it is inappropriate to
approach family members/proxies due to their being
distracted and distressed [6, 7]. To help address these
challenges, and enable trial research to be undertaken in
emergency situations without delaying treatment, more
flexible approaches to gaining consent have been advo-
cated and developed, which balance the need for consent
and participant protection against the need for research
to be undertaken [8, 9]. At one extreme, this involves
use of consent waivers where participants are recruited
to trials without consent being taken [5, 8]. However,
deferred consent (i.e. enrolling an individual into a trial
and seeking consent retrospectively) tends to be a pre-
ferred approach, especially in clinical trials where obtain-
ing prospective consent might lead to harmful delays to
the initiation of treatment [4, 6, 7]. While ethical con-
cerns have been raised about not informing patients/
proxies about trial participation, or only doing so retro-
spectively, consent waivers and deferred consent proce-
dures have been seen to play an important role in
advancing trial research and, hence, the development of
treatments used in emergency settings [8, 10]. As well as
being the subject of ethical attention and debate [8, 10–
13], use of consent waivers and deferred consent proce-
dures has received some empirical attention. For
instance, questionnaire and qualitative studies have
reported patient/proxy [7, 14–16] and health profes-
sional [7, 15, 17, 18] support for use of deferred consent
in emergency research, although it has also been found
that health professionals may initially be reticent about
using what they see as an unorthodox approach [18–20].
Studies which have explored patient, public and profes-
sional opinions about use of consent waivers have
revealed a much more ambivalent picture, with research
regulators being more cautious about their use than
patients and health professionals [5, 15].
Alternative scenarios for gaining consent, which poten-
tially a steer the middle ground, have received surprisingly
little empirical attention. This includes use of verbal con-
sent at the time of trial enrolment followed, at a later
stage, by written consent, an approach which has been
advocated by some clinicians and bioethicists [21, 22] as it
“balances the pressing need to conduct research in the
emergency setting with an ethical approach which strives
to inform and consult patients before their participation”
[22]. Such an approach has also been endorsed by the
Royal College of Obstetricians and Gynaecologists in
recent guidance about obtaining consent in peripartum
(around the time of birth) research where consent is time
critical. These guidelines state that: ‘[in acute circum-
stances]…provision of antenatal information to women
with brief oral consent at the time of the complication is
appropriate. Full written consent is then obtained at a
later stage’ [23]. This approach to gaining consent is being
offered as part of an on-going clinical trial, the Glyceryl
Nitrate for Retained Placenta (GOT-IT) trial, which
involves recruitment of women at a time of obstetric
emergency due to them having a retained placenta. As
well as using a summary participant information sheet,
the trial protocol and associated ethical approvals permit
women to give verbal consent at the time of enrolment
with written consent taken as soon as possible after trial
participation. If a woman chooses to give verbal consent,
she is given the summary information leaflet (which she
can read if she wants) and the trial is explained to her. If
the trained person is happy that the woman understands
what trial participation involves, the recruiter is allowed to
take her verbal consent. This is recorded in the woman’s
medical records and is then followed up by formal written
consent as soon as is possible in the postnatal period. The
decision to include this approach was made because it
was recognised that a retained placenta is a potentially
life-threatening complication with the amount of blood
loss increasing the longer a placenta is retained. It was also
recognised that, due to the emotional and physical impact
of birth, women might find it burdensome to complete
and sign the form at the time of recruitment and, hence,
might prefer to give initial verbal consent. The trial
included an internal pilot, during which exploratory
qualitative work was undertaken with women and trial
staff to explore their views about the trial’s recruitment
and consent procedures. One of the objectives of this
work was to provide recommendations for use in future
trials involving recruitment and consent of individuals
in emergency situations.
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In an earlier paper [24], we reported women’s and trial
staffs’ views about the timing of the recruitment
approach, which took place immediately after diagnosis
of a retained placenta, and the content and delivery of
trial information. As we described, women appreciated
being given access to a summary participant information
sheet at the time of recruitment, as they considered the
full version too lengthy and time-consuming to read.
Many also highlighted the benefits of having staff
present to explain the trial, as, due to exhaustion, they
had found even the summary participant information
sheet too burdensome to read. Relatedly, many women
described how they had wanted and appreciated oppor-
tunities to expedite the recruitment process. This was
because they had been eager to try the trial intervention
at the earliest opportunity as they thought this might
prevent from them from having to go to theatre and,
hence, allow them to be there for their baby. For similar
reasons, staff also supported use of summary informa-
tion sheets and verbal information delivery approaches.
Not only were these seen to streamline and expedite the
recruitment process in a context where there was limited
time in which to recruit and consent, staff also suggested
that they had enabled information to be imparted in
clear and easy to understand ways [24].
In this paper we consider the culmination of the
recruitment and consent pathway: the giving and docu-
mentation of consent. Specifically, we will consider why,
despite some women and staff highlighting the potential
benefits of giving verbal consent at the time of recruit-
ment, most staff who had direct responsibility for gaining
consent from women into the trial expressed extreme
reluctance to proceed with enrolling women into the trial
until written consent had been obtained.
The research setting: The GOT-IT trial
As described previously [24, 25] the GOT-IT trial is a ran-
domised placebo controlled double blind pragmatic RCT
involving women who have a retained placenta recruited
from delivery wards in the United Kingdom (UK).
Retained placenta is a major cause of postpartum haemor-
rhage and affects around 2% of vaginal deliveries in the
UK. It is diagnosed when the placenta is not delivered
within 30 min following active management or 60 min
after physiological followed by active management of the
third stage of labour after delivery of the baby [26]. The
aim of the GOT-IT trial is to determine whether use of
Glyceryl trinitrate (GTN) spray, as compared to a placebo,
can facilitate delivery of the placenta without having to
undertake manual or surgical removal of the placenta in
theatre. Once a diagnosis of retained placenta has been
made, women are recruited into the trial by a member of
the clinical or research team who has received appropriate
training and has delegated responsibilities to take consent.
The trial comprises an internal pilot followed by a sub-
stantive RCT. The pilot ran from October 2014 to April
2015 and involved eight sites, which were entered in a
phased way. The purpose of the internal pilot was to
provide evidence and reassurance of the feasibility and
effectiveness of all trial processes, including those relat-
ing to recruitment and obtaining informed consent. The
substantive trial is due to be completed in 2017.
Methods
Qualitative study design
The qualitative research explored women’s and staff
experiences of, and views about, the recruitment and
consent procedures used during the pilot, including the
giving/soliciting and documentation of informed con-
sent. Full details of the design have been reported previ-
ously [24, 25]. In brief, in-depth interviews, informed by
topic guides, were used as the method of data collection,
as these afforded the flexibility needed for participants
to raise and discuss issues that they perceived as salient,
while helping to ensure the discussion stayed relevant to
addressing the study objectives. Interviews also afforded
privacy, allowing participants to share negative views, if
they wished to do so. The study employed an iterative
approach that entailed simultaneous data collection and
analysis [27].
Sample and recruitment
Recruitment to the qualitative research was undertaken in
all eight centres involved in the pilot between November
2014 and April 2015. Women were approached within 2-3
days of having taken part in the trial and were either given
a recruitment pack while in hospital, or a pack was posted
out if they had already been discharged. Staff were given
or sent recruitment packs. The study information sheets
for both women and staff made it clear that the interviews
were being conducted by independent researcher (NH),
who was not a member of the trial team. Individuals were
also reassured that all information disclosed would be
treated in confidence, with only anonymised findings
being fed back to the trial team.
Women were purposively sampled so there was diver-
sity in the final sample in terms of age, education/occu-
pation, parity and ethnicity (see Table 1). Staff were
selected for interviews if they had been involved in trial
delivery, recruitment or gaining consent from women.
Across the centres, these staff comprised research mid-
wives and obstetricians and midwives who were working
clinically on the delivery suite. All participants gave their
written informed consent to take part in an interview.
Recruitment into the qualitative study was necessarily
constrained by the relatively short duration of the trial’s
pilot phase and the staggered entry of the sites into the
pilot; this also limited the number individuals who could
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be approached to take part into the qualitative study.
However, despite these restrictions, it was possible for us
to continue to recruit until we got good representation
of participants (women and staff ) from across the pilot
sites and had collected sufficient data to allow a diversity
of perspectives and views to be captured and explored
in-depth.
Data collection and analysis
The topic guides for the interviews were developed in
the light of literature reviews, inputs from staff and lay
advisors, and revised in light of emerging findings. Key
areas explored included: women’s experiences of birth
and of being approached to take part in the trial;
women’s views about consent procedures used and how
these might be improved; staff experiences of delivering
trials prior to GOT-IT; staff views about the consent
procedures used in GOT-IT; and, reasons for using writ-
ten and/or verbal approaches during the pilot phase.
All interviews were digitally recorded and transcribed
in full. Data were analysed thematically by JL and NH
using the method of constant comparison [28]. This
approach entailed individual interviews being read
through repeatedly before being cross-compared to iden-
tify issues and experiences (i.e. themes) which cut across
different accounts. A comparative analysis of women’s
and staff accounts was also undertaken to identify differ-
ences and similarities in their views about the consent
procedures used. JL and NH undertook independent
analyses before meeting to discuss their interpretation of
the data, resolve any differences in opinion and to reach
agreement on key findings and themes. A coding frame
was then developed which captured and encapsulated
these themes. As JL’s and NH’s initial analysis made ap-
parent, women’s accounts of the consent procedures
used during the pilot were relatively straightforward,
with only two key (divergent) perspectives being
reported. Staff, however, tended to provide much more
in-depth, complex and nuanced perspectives and views.
For this reason, coded datasets from the staff interviews
were subjected to further, in-depth analysis to identify
additional (sub-) themes, together with contextual infor-
mation needed to aid interpretation of the data. As part
of the data analysis process, the qualitative analysis soft-
ware package NVivo9 (QSR International) was used to
facilitate data coding and retrieval.
Ethical approval for the trial and the qualitative
research was given by Newcastle and North Tyneside 2
Research Ethics Committee. To safeguard confidentiality,
all participants (women and staff) were allocated pseudo-
nyms and these are used below.
Results
Forty-nine women and 37 staff were invited to partici-
pate. Twenty-two (45%) women and 27 (73%) staff were
interviewed (10 doctors and 17 midwives). Of the 27
staff interviewed, twelve had been involved in obtaining
consent from women for entry into the trial (see Table 2);
the remainder (6 clinical midwives, 11 research mid-
wives) were able to make initial approaches about the
trial but were unable to obtain consent. Given the focus
Table 1 Participant Characteristics – women
N %
Age (years)a 30.1 18–40
Ethnic Group
White British 17 77
South East Asian 2 9
Other 3 14
Highest education level
School 7 32
Further education 2 9
Degree 8 36
Higher degree 5 23
Previous birthing experience
Primigravidas 9 41
Previous retained placenta 5 39
aMean: Range
Table 2 Clinical and Previous Trial experience of staff involved
in gaining consent from women into the GOT-IT pilot
Pseudonym Job title Previous clinical
trial experience (Y/N)
Previous peripartum
trial experience (Y/N)
MWA Research
midwife
Y N
MWC Research
midwife
N N
Dr A Obstetric
Consultant
Y N
Dr B Junior
traineea
N N
Dr C Junior
traineea
Y N
Dr D Junior
traineea
Y Y
Dr E Junior
traineea
N N
Dr F Senior
traineeb
N N
Dr G Junior
traineea
N N
Dr H Consultant Y N
Dr I Consultant Y Y
Dr J Junior
traineea
Y N
a < 5 years in training post, b5–7 years in training post
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of this paper is upon soliciting/giving and documenting
informed consent, when staff perspectives are reported,
we borrow heavily on the accounts of those who had
direct responsibility for taking consent from women for
trial entry. However, as other staff members did observe
consent interactions and had opinions to share, their
perspectives, albeit to a lesser extent, have also been
included.
Below, we begin by reporting women’s’ perspectives
and views before we go on to consider staff accounts. As
we show, while staff, like some women, highlighted
potential benefits to using verbal consent at the time of
recruitment, those who were responsible for obtaining
this consent were reluctant to proceed with enrolment
until women had completed and signed a consent form.
Analysis of the staff interviews, as we further show,
revealed a variety of factors (sub-themes) which helped
to account for their unwillingness to forgo written
consent at the time of recruitment.
Women’s experiences and views
All women interviewed described having given written
consent at the time of recruitment. Resonating with their
broader, and generally positive recruitment experiences
[24], most women also presented the completion and
signing of the consent form as having been relatively
straightforward and unproblematic. Indeed, typically, the
giving of written consent was mentioned in passing, and
described in a matter of fact tone, as part of a broader
account of their recruitment experiences, as Anna’s
quote serves to highlight:
“I mean they said, you know, “it’s just going to be a
spray and, you know, there is a chance that you’ll get
the placebo” and just all of the basic detail. I’m sure if
I’d have asked more questions it would have been
fine, but I was just happy to have a quick read
through and sign it.” (Anna)
However, almost a quarter of the sample (n = 5) indi-
cated that they had found the experience of completing
and signing the consent form at the time of enrolment
burdensome or unwelcome. This included Kate, who
had had a 30 h labour which had left her both physically
and emotionally exhausted, and who suggested that:
“the only thing personally I would change is signing
consent form really… but when you’re in that
moment when you have just given birth and you’re in
pain, your head’s a bit dazed really to be signing
things like that is a bit too much… you have to initial
quite a lot [of boxes], you know, to say you’ve
understood certain parts and then you have to sign it
at the bottom.” (Kate)
A similar, albeit more extreme view, was conveyed by
Hannah, who, like Kate, had had a lengthy and exhausting
labour, and who intimated that, by asking her to give
written consent at the time of recruitment, staff had not
been sensitive to her physically compromised state:
“The doctor we’d seen, she was quite hard, she was
more interested in me signing the bleeding form while
I couldn’t even hold my head up. And the signature
on the form, I mean, if you’d seen it, I don’t know, it’s
literally a line I just dragged my hand across the
thing.” (Hannah)
Others not only described having been too weak and
exhausted to complete the consent form with ease, but
also highlighted a preference for verbal consent because
this would have allowed their entry into the trial to be
expedited. This included Trina, who had been induced
at 36 weeks due to pre-eclampsia, and who had had a
very quick delivery as a consequence, which she
described as having resulted in her body having “gone into
shock”. She also reported how, at the time of recruitment,
she had been extremely worried about her new born baby
who had been admitted to the Special Care Baby Unit.
Trina presented two overlapping rationales for why she
would have benefitted from “giving oral consent with
the forms are brought to you at a later stage.” First, like
Kate and Hannah, she highlighted her physically com-
promised state and, hence, her desire to “get on with
it”, second, as her quote below makes apparent, she had
wanted to be with her baby without delay:
“… obviously I was quite poorly at the time … so I
just wanted to get on with it… And I just wanted to
get it over with [administration of the spray] so I
could be there for my baby.”
Staff perspectives and views
Mirroring the accounts of those women who had found
completion of the consent form at the time of recruitment
burdensome, some staff who had witnessed the recruit-
ment and consent process highlighted the importance and
value of having the option of using verbal consent proce-
dures. This included MW J who reflected upon how:
“It can be tough, I will say it, because obviously if the
lady’s had a long labour and she’s maybe been on the
labour ward for, you know, 15, 20 hours or something
like that, it must be exhausting. But the good thing is
you can get verbal consent so you’re not having to
push pieces of paper in front of them… So they can
do verbal consent as long as they document it and
they’ve explained it all to them and then go back
retrospectively and get them to sign after that.” (MW J)
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Not only was obtaining verbal consent seen as way of
reducing the stress and demands placed on those who,
as a result of their birth, had been left exhausted, some
staff also highlighted the benefits of expediting the con-
sent process because, as MW N noted “when a woman’s
just had a baby there’s a lot going on in their mind and
they just want to see their baby.” This view was rein-
forced by MW D who concluded that, in some situations
at least, “I’d much rather get verbal consent and then do
the written afterwards” after having observed a woman
who, as she described,
“had just wanted to get on with it… but the consent
form was quite lengthy. There was a lot on it and a
lot of boxes to sign, and she just wanted to crack on
because she was in a bit of pain, she’d just had a baby,
and the baby was crying.” (MW D)
There was thus, in principle, support from some staff
who had observed the consent process for offering the
option of prospective verbal consent during this peri-
natal trial. However, amongst those staff who had direct
responsibility for obtaining consent from women, there
was widespread reluctance, in practice, to forgo written
consent procedures at the time of trial enrolment. Spe-
cifically, of the 12 individuals who had been involved in
gaining consent from women, only two indicated a will-
ingness to use a verbal consent when women were en-
rolled into the trial. Furthermore, during the interview
study, which spanned a seven month period, none of
those interviewed could point to any instances where
verbal consent had actually been used either by them-
selves or their colleagues. Below we consider reasons for
staff reluctance to forgo written consent at the time of en-
rolment in more detail, beginning with experiential factors
(former trial and clinical experiences) before moving onto
consider more nuanced ethical issues and concluding with
practical considerations.
Experiential factors – former trial and clinical experience
“The studies that we’ve worked on have always been,
you know, in the antenatal period. And we’ve never
had to – with any of our research studies, we give our
women 24 hours, and, then, they have time to think
about it.” (MW M)
As Table 2 reports, it was not unusual for the staff
who took consent during the GOT-IT pilot to have been
trial inexperienced or naïve. Furthermore, as MW M
(quoted above), like some others, pointed out, even
when staff working on GOT-IT had not been trial-naïve,
their experiences in trial recruitment and consent had
tended to have been restricted to antenatal trials where
women are usually given at least 24 h to consider their
participation before the informed consent is taken. As
various individuals noted, this had meant that, even if
staff had had prior experience of obtaining consent from
potential participants, this experience had not generally
prepared them for GOT-IT. As Dr B and Dr E, like
others observed, this was because the circumstances in
which recruitment and consent were undertaken were
substantively very different to antenatal and other trials,
due to recruitment being undertaken in an emergency
situation and, relatedly, to there being very limited time
available to take informed consent:
“I’ve been involved in quite a few [clinical trials] but
not intrapartum, [trials during labour] the majority
I’ve been involved with have been antenatal at
different stages of pregnancy, which is very different
from the [GOT-IT] approach because intrapartum,
there’s not the same time for reflection and
consideration about whether somebody wants to take
part, it’s a little more urgent… there’s this element of
someone’s had a baby, the placenta’s not come out,
and there’s very limited time to have a discussion
about this.” (Dr B)
“it’s been interesting actually being involved in a trial
like GOT-IT– well one that is on the delivery unit, in
an environment that people aren’t used to having
clinical trials. You know, they’re in quite a sort of high
stress, quick turnaround, fast paced environment… it’s
an interesting environment to consent patients for a
clinical trial. Because it’s quite different to a sort of,
you know, sit down clinic, have a think about something,
then write to me if you’re interested. That’s the thing,
it’s kind of a now or never scenario.” (Dr E)
Not only were many individuals new to the kind of
“now or never scenario” (Dr E) which the GOT-IT trial
had presented, some staff also noted that the majority of
those who had been involved in obtaining consent for
the trial had been relatively junior and clinically inex-
perienced. Such a situation, as MW J pointed out, was
fairly inevitable because recruitment had, by necessity,
to take place as and when a retained placenta was diag-
nosed, including at night-time and over the weekend,
when the more senior and experienced staff were less
likely to be on duty:
“I am not saying the doctors [who are obtaining
consent for GOT-IT] have never consented anybody
to a study, possibly at other hospitals, but in our site
certainly, it’s mostly the consultants [who’ve consented
into other trials] whereas, for GOT-IT, the registrars,
they’ve tended to be ones I’m having to get to do A and
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B, because they’re the ones on the labour ward, the
consultants are at home, they’re not working at the
weekends.” (MW J)
Staffs’ relative inexperience of recruiting into peripar-
tum and other trials, as some individuals, including MW
F, further reflected, had potentially resulted in a more
risk averse approach having been adopted, which had led
to a greater onus having been placed on the consent
form being completed at the time of recruitment:
“It’s kind of a new thing for the doctors, research, for
[site name], is quite new, they’re just getting used to
it…So the doctors haven’t recruited per se from [site
name] that much… So I think probably more from a
point of view that they feel they have to do it, you
know, getting the form signed, just to be on the
safe-side that they’re doing it correctly.” (MW F)
Indeed, it is notable that one of health professionals
(Dr D) who did indicate a willingness to forgo written
consent at the time of recruitment had previously been
involved in another peripartum trial in an emergency
setting [29]. In this trial, as Dr D noted, it was possible
to forgo getting written consent at the time of recruit-
ment if the woman was facing a life-threatening postpar-
tum haemorrhage:
“they didn’t have written consent, because that was,
well I think it was, as a clinician, if you thought it was
in the best interest to give it, I think you just entered
the woman into the trial.” (Dr D)
Others indicated that clinical trial research, by its very
nature, fostered a risk averse approach: “it’s just the
words, clinical trial, I think that make people, don’t
know, feel like they need to be extra cautious” (Dr E),
because this kind of research entails investigation of
drugs or procedures of unknown clinical efficacy in the
context of the field of investigation. Indeed, some indi-
viduals indicated that, because of this precautionary
stance and their prior experiences of having worked on
non-perinatal trials where written consent was always
obtained prior to administration of the study drug/pro-
cedure. As a consequence, soliciting written consent at
the time of enrolment had, for them, become a condi-
tioned and taken-for-granted practice:
“I would feel less comfortable about that [taking
verbal consent initially and getting written consent
later] because you get so used to doing written
consents for clinical trials for any sort of significant
intervention you get used to doing written
consent.” (Dr E)
Ethical and perceived legal considerations
As these and other staff noted, reluctance to forgo written
consent procedures during GOT-IT often occurred despite
their being familiar and comfortable with using verbal
approaches when gaining consent from women to go to
theatre and undergo other emergency procedures in their
routine clinical practice on the labour ward. To help
account for these differences in their approaches for
obtaining consent, these staff typically drew a strong dis-
tinction between trial research and clinical care. In the lat-
ter, staff described acting in a patient’s best interests,
whereas, in the former, the interests of a wider clinical (i.e.
non-trial) population was their paramount consideration:
“Well it is different because – well firstly the fact that
the drug that you’re consenting - you’re offering them
something which is - you’re not trying to tell them,
this is something you should have because it will save
your baby kind of scenario. It’s very much, this is
something you really don’t have to have, but taking
part in the study will potentially give us help in the
future to know whether this is a good treatment
option or not.” (Dr A)
“I guess it is difficult with all women, I think, isn’t it
in labour and delivery and post-delivery about
consent, even consenting for things like caesarean
sections and forceps, about how much of it can really
be truly informed consent, given how tired and things
they are…I definitely think there are times when you
can question how much the woman is really taking in
of what you’re saying. But it’s a bit different when
we’re suggesting or saying what we would recommend
is definitely what we feel is in their best interests.
Which is slightly different to a trial, isn’t it, cause
you’re not offering them the best, you know, the gold
standard treatment, you’re offering them something
slightly different.” (Dr B)
Indeed, as Dr B noted, while there are challenges to
obtaining consent from women for emergency proce-
dures in routine clinical practice due to their being
exhausted, taking consent in such situations also tends
to be seen as being relatively unproblematic and uncon-
troversial. This is because, as this individual further
pointed out, the recommended course of action tends to
be delivery of a ‘gold standard’ treatment or procedure
of known clinical efficacy. In addition, as Dr F and Dr E
indicated below, in many of the emergency situations
encountered during their work as obstetricians, there are
often no alternative, clinically viable treatment options
to offer. Hence, as these individuals intimated, when
they gained consent from women in clinical situations,
rather than encouraging engaged and reflexive decision-
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making, they were ostensibly seeking their permission to
proceed along a pathway which they saw as being in a
woman’s best clinical interests:
“Yeh well that thing of acting in their best interest; I
think probably because this issue about not going to
theatre is that you could then bleed and maybe need a
transfusion, and often if the placenta hasn’t come by
about an hour …. you’re then deciding that the course
of action is to go to theatre to avoid the woman from
bleeding, so you’re deciding, you’re kind of doing a bit
of a paternalistic one saying, “well this is what we
have to do now, so although I want you to consent to
it, I’m not really giving you an alternative”, because
we don’t want to leave people’s placenta in do we….if
you’re consenting for theatre, you’re thinking well this
is in this woman’s best interest to stop her from
bleeding, to stop any further complications…so you’re
thinking well it’s the best course of action and what
else are we going to do.” (Dr F)
“But there are occasions [in emergency situations in
routine clinical practice] when it’s extremely rushed and
we – you don’t have time to get the patient to sign the
consent form. So those you can always justify, cause it’s
a matter of life and death to the baby, kind of thing that
you would – that it feels okay to miss out on that
written consent for the sake of safety.” (Dr E)
Dr F and Dr E were the only two health profes-
sionals who indicated or implied that it is acceptable
to adopt a paternalistic or directive stance when tak-
ing consent from women in routine clinical practice.
However others, like Dr F and DR E, were keen to
draw a distinction between the kind of consent which
they felt was needed to undertake emergency proce-
dures in their everyday work as obstetricians, and
what Dr I, below, described as the “higher” (i.e. more
informed) level of consent required for a clinical trial
such as GOT-IT:
“To be honest, I think a lot of consent taken is, half
the signatures on the paper aren’t worth the paper
they’re written on. You know, we get consent for
caesarean sections in traumatic situations as people
are being wheeled down the corridor and everything.
But I know the level of consent has to be higher when
it’s research, because its research.” (Dr I)
Indeed, such staff were not only keen to emphasise
that “the understanding of the woman has to be better
because you’re giving a drug or procedure you wouldn’t
normally give” as Dr I, quoted above, went on to elab-
orate, they also noted that, because a women might not
gain any clinical benefit from taking part in the trial,
she needed to make a more active and voluntary deci-
sion to participate:
“I don’t know that I would feel that comfortable
[getting verbal consent] about it because it’s not, I
suppose that kind of taking verbal consent from people
is more when you are acting in their best interests and
a trial is a trial and that’s useful for us, but it’s not
necessarily in the patients’ best interests. So then it
should be that they completely choose it.” (Dr A)
It was partly because staff saw trial participation as re-
quiring active decision-making wherein a woman should
“completely choose it” as Dr A put, that some, including
Dr I, suggested it was important that the consent form
was completed before trial entry. As this individual indi-
cated, this was partly because the act of completing the
form helped to create a situation that encouraged a
woman to reflect upon the decision she was making:
“I know legally, I think it’s not binding the written
consent, but I think it gives them an extra bit of time to
firmly say, yes, yes I would like this. So yeah I’d feel a
lot more comfortable getting written consent.” (Dr I)
Written consent at the point of study entry: protection for
staff gaining consent
For others, the importance attached to completing the
consent form appeared to be less about creating an
environment that fostered informed decision-making,
and more about providing tangible “proof” that a
women had actively agreed to take part, which could
help protect them from subsequent complaints and
litigation:
“I don’t feel comfortable with any other consent, I
think unless it’s an emergency where, you know, we
do sometimes come across emergencies where we
have to seek verbal rather than written. I wouldn’t be
comfortable seeing verbal consent in this situation [I:
and why wouldn’t you] – if she does get side effects
from it and she becomes hypotensive or she becomes
unwell, or if she starts bleeding, anything. She can
blame it on anything. And she might tell me that she
hasn’t been informed. And I don’t have any proof of
that because there is no documentation. (Dr C)
“So I think, in the occasional patient, that is feeling
- like the one saying the other day, ‘am I a guinea
pig. I- am I the first person who’s done it?’ I think
those people that are- not sceptical, but very inquisitive
as to, ‘well why are you doing this to me?’ I dunno,
they’d be willing to take part, but I think they would be
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quick to blame the trial if anything went wrong, even if
it was 24 36 hours later. And I think, in those situations
I’d feel more comfortable with them having a written
consent” (Dr B)
While such staff indicated that they felt more vulner-
able to complaints when patients took part in clinical
trials, precisely because they might receive a treatment
that was not in her best clinical interests, they also
suggested that this kind of vulnerability was heightened
in a perinatal trial such as GOT-IT. This, as they pointed
out, was because recruitment had, by necessity, to be
undertaken at a time when a women might be exhausted,
distracted and/or under the effects of analgesics. As
reported previously [24], despite these mitigating fac-
tors, staff conveyed general confidence that they had
been able to secure informed consent at the time of
recruitment; in large part because of their perceived
ability to convey information about the trial in clear
and accessible ways [24] and because they saw GOT-
IT as a relatively easy trial to understand and explain
[24]. However, as Dr A indicated below, some staff
also expressed concerns that, because consent was
taken at a time when a woman might be physically
and emotionally exhausted, she might subsequently
forget or struggle to recall all the details of the con-
sent procedure:
“it’s quite an emotional moment – a lot of the time
they’re very upset because they’ve had a normal
delivery and they’re very pleased with the birth plan
and now suddenly they’re being told they may have to
go to theatre.. so whatever you tell them at the time,
they’re not going to remember, and that’s why it’s
important to have the security blanket of something
in writing.” (Dr A)
Hence, staff highlighted the need for “the security
blanket of something in writing”, as Dr A put it, not only
because this evidenced a woman had given her consent
at the time of recruitment, but also, as Dr H elaborated,
to demonstrate that all of relevant discussions had taken
place prior to that which are necessary for making a fully
and properly informed decision:
“I mean consent, we have it written down as evidence
but actually the consent process is that
acknowledgement that the patient does understand
what he or she is going forward with and you can
never consent without a verbal discussion first… as a
practitioner you need to understand yourself that the
patient has understood so it needs to be a two way
dialogue and writing down is really just a
confirmation of that.” (Dr H)
In terms of establishing understanding on the part of
the woman, a couple of health professionals also
suggested that they attached credence to the completion
and signing of the consent form as, in their opinion, the
physical act of doing this could be considered a proxy
indicator of competence. Indeed, it was precisely be-
cause writing was seen as a surrogate for understanding
and competence that some health professionals, includ-
ing Dr H, suggested that they would exclude a women
from the trial if she was unable to complete the consent
form at the time of recruitment.
“Yeah, no, I think my being uncomfortable isn’t to do
with the signing of the paper work in advance. It is to
do with the: if they are at a point where they are
unable to do that, is that a reflection of their sort of
lack of competence actually to make a decision for
themselves… I think our concerns as clinicians, well
certainly mine would be: if they’re so exhausted that
they’re not able to, you know, able to sort of written
consent, even you know, just a one signature on one
line, em yeah, if they’re not able to do that then I
would be concerned that they weren’t actually
understanding and weighing up the information, you
know, retaining it long enough for them to actually
make a decision which was their own sort of
competent decision.” (Dr H)
Practical reasons for obtaining written consent at the time
of recruitment
While staff directly involved in gaining consent from
women provided, in the main, ethically (and legally)-
informed reasons for wishing to obtain written consent at
the time of recruitment, they and their midwifery
colleagues had additional, more practical insights and
explanations to offer. In particular, staff highlighted the
logistical reasons for asking women to complete the con-
sent form at the time of recruitment. This, as they noted,
was because, in the delivery wards were most recruitment
took place, workloads could be very heavy and unpredict-
able. Hence, as MW K pointed out, there was a possibility
that the staff member responsible for gaining consent from
a woman could get called away and might not be able to
return a later stage to ask them to complete the form:
“And maybe possibly because they think “well, if this
works and we get called away then we need to come
back to the room and consent her” whereas they might
be called into another room or they might be called
into theatre. So it’s maybe just a matter that they’re
thinking “well, if I get it done now and the woman’s
coherent and she’s able to do it then and there then I’ll
just get it done so that it’s, you know, time-specific and
I’m not having to return to the room.” (MWK).
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Some staff also noted that, if the form needed to be
competed retrospectively, there was no guarantee that
there would be a staff member on duty at the time who
was on the delegation log and, hence, able to take the
consent. As MW A further suggested, there was also a
possibility that by the time a delegated and trained staff
member, such as themselves, had come on duty, a
woman might have already been discharged:
“if it happens on a Friday and you’re not in till the
Monday and the woman’s gone home, it’s a bit more
of a nuisance.” (MW A)
Discussion
This study has explored patient and staff experiences of,
and views about, a consent process which has been
advocated for use in some trials involving recruitment in
emergency situations: the option of using initial verbal
consent followed later by written consent [21–23, 30].
As we have shown, women who took part in the GOT-
IT pilot endorsed use of initial verbal consent, especially
those who had been left exhausted by their births and/or
who had wanted to truncate the consent process in
order minimize time spent away from their new born. In
keeping with these women’s accounts, some staff who
had observed practices of gaining consent during the
pilot also highlighted the potential benefits of using a
verbal approach at the time of enrolment. However, dis-
cordant views were expressed by the vast majority of
staff who had direct responsibility for enrolling women
into the trial, despite these individuals wanting to exped-
ite recruitment and reduce the burden placed on poten-
tial recruits [24]. To account for their resistance to forgo
prospective written consent, these staff members drew a
distinction between research and clinical care, one which
is well recognised in bioethics literatures [31, 32]. In
doing so, staff emphasised the need to engage women in
a reflexive decision-making process to help ensure they
made an active and voluntary choice to take part in a
trial that, by its very nature, could not guarantee that ad-
ministration of the trial drug would enable the placenta
to be delivered. Staff also highlighted the role that com-
pleting and signing the consent form at the time of en-
rolment could play in helping to reinforce and provide
evidence of a reflexive and informed decision-making
process. While most staff cited their ethical responsibil-
ities to women as the rationale for asking for prospective
written consent, their accounts also revealed a seemingly
risk averse approach. Specifically, some staff highlighted
a (mis)perception that the absence of a signed consent
form at the time of trial enrolment could expose them
to greater risk of litigation were a woman to experience
a problem or complication during the trial. Others
voiced concerns that it might prove difficult to get the
form completed after the trial, especially if a woman had
already been discharged.
In keeping with these findings, other research also sug-
gests that concerns about litigation may impact on the
conduct and preferences of staff involved in obtaining
consent for participation in emergency trials. This
includes survey research undertaken with Polish emer-
gency stroke clinicians which found that, despite there
being no legal requirement to do so, more than 50%
sought parallel consent from patients’ relatives [4].
Moreover, while most clinicians endorsed use of a trun-
cated consent process, only 7.5% supported forgoing
prospective written consent [4]. While highlighting po-
tentially important issues, the authors, however, were
unable to provide explanations for these findings. In
another questionnaire study that explored health profes-
sionals’ views about using deferred consent in paediatric
and neonatal emergency care trials, Woolfall and col-
leagues found that staff held negative perceptions and
views about this consent pathway. Interestingly, however,
these negative perceptions were restricted to staff who
had no prior experience of deferred consent; practi-
tioners experienced in this method were much more
positive about its use [19]. Indeed, companion qualitative
research highlighted how health professional views about
using deferred consent could change in light of their
experiences of using this method and seeing a positive
impact on recruitment, decision-making capacity, and
practitioner-parent relationships [18]. While Woolfall et
al.’s research focused on deferred consent procedures, it
is relevant to the current study as it draws attention to
how staff (in)experience may impact on their confidence
and willingness to recruit into trials without obtaining
prospective written consent. Indeed, in keeping with
Woolfall et al.’s observations, some of the individuals we
interviewed suggested that reluctance to forgo prospective
written consent during the GOT-IT pilot had arisen in
part from the relatively junior status and inexperience of
most staff who had been involved in obtaining consent
from women for trial participation. Further paralleling
Woolfall et al.’s observations, it is interesting to observe
that one of the staff who said they were willing to forgo
verbal consent for the GOT-IT trial had had previous
experience with another peripartum trial in an emergency
setting which used prospective verbal consent.
Staff (in)experience is an important issue to consider
in the design and delivery of future trials which require
truncated recruitment and consent approaches to be
used, particularly where the responsibility to consent
may fall to junior clinical staff who are emergency trial
naïve. This is particularly relevant to peripartum trials
where the junior clinical trainees are often based in
delivery suites and responsible for dealing with peripar-
tum emergencies. Because of time-critical nature of
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recruitment in these kinds of trials where delaying
definitive management risks patient safety, junior staff
may thus best placed to obtain consent. As the findings
of this and other studies indicate, staff who are inexperi-
enced in using alternatives to prospective written con-
sent may benefit from training and support to increase
their confidence and willingness to use alternative con-
sent approaches. This training and support could focus
on raising staff awareness and understanding of ethical
review processes and of how, and why, they are legally
protected when alternatives to prospective written con-
sent are used [17]. During training, staff may also be
encouraged to consider how obtaining prospective writ-
ten consent may lead to avoidable delays to starting
treatment, which as Roberts and colleagues argue, may
obscure real treatment benefit as well as resulting in
avoidable morbidity and mortality is some kinds of
emergency trials [9]. Given the relatively high turnover
of junior clinical staff in obstetrics and other clinical spe-
cialities, we would recommend that training and support
continues throughout a trial’s recruitment phase. We
would also recommended that, in each trial site, as many
staff as possible are trained up to take consent. As our
findings indicate, this might help alleviate pressures
staff feel to obtain prospective written consent due to
their concerns that there might not be suitably dele-
gated and trained staff available to obtain this consent
retrospectively.
Commentators advocating use of initial verbal consent
in emergency medical research have also recommended
that this consent be observed and documented by a
patient advocate [21, 22], a role filled by health care pro-
fessional who is independent of the research team, and
who is in a position to interpret the patient’s condition
and responses to the researcher [22]. Such individuals
were not used in the GOT-IT pilot, and it is possible
that, if they had, this might have helped alleviate staffs’
perceived need to get written consent at the time of trial
enrolment. In particular, having an independent witness
observe the consent process might have helped address
staff concerns about needing to evidence that all rele-
vant information had been given and that all relevant
discussions had taken place. In addition, health profes-
sionals might not have attached such credence to the
signing and completion of the consent form, if compe-
tency could have been confirmed by an independent
witness. Use of patient advocates could be considered
in future trials involving recruitment in emergency situ-
ations, as well as being the subject of future (qualita-
tive) research. However, in peripartum trials, such as
GOT-IT, logistical issues may also need to be considered
and addressed. This includes the potential difficulties of
accessing an independent health care professional, espe-
cially if recruitment needs to be undertaken at times (e.g.
late at night) when staff availability may be limited and
where delaying recruitment to the trial potentially risks
patient safety.
By using an open-ended, qualitative approach, it has
been possible to provide a level and depth of insight that
has not been possible in studies that have solicited staff
views using questionnaire designs [4, 19]. An additional
study strength is our decision to draw upon the perspec-
tives and experiences of women as well as trial staff. By
showing that women and staff may hold discordant
views, our study supports recommendations, made pre-
viously [24] and by others [15, 17–19], that different
stakeholder groups, including patients and healthcare
providers, should be involved in the development and
evaluation of study protocols and consent procedures
used in future emergency trials. Of the 27 staff we inter-
viewed, only twelve were able to consent women into
the trial and, given the focus of this paper, these staff
members’ accounts were drawn upon most heavily in
our analysis. Because this is a relatively small sample
size, we cannot guarantee data saturation was achieved;
however, we have been able to capture some of the com-
plexities and nuances informing staff decision-making
and consent preferences at the time of trial enrolment. It
should be taken into account, however, that some staff
who obtained consent might have used their interviews
to present themselves in a favourable light; this includes
the possibility that they provided post-hoc rationalizations
to justify their decisions to press for written consent at
trial enrolment.
Conclusion
Alternative consent pathways, such as use of initial verbal
consent, have an important role to play in advancing
emergency medicine research. However, while potential
trial recruits may appreciate use of such approaches, they
may present unintended logistical challenges and ethical
and legal concerns to recruiting staff. Our research high-
lights the importance of drawing upon a stakeholder
perspective at an early stage in the research process to
understand and explore how alterative consent pathways
are used. Furthermore, our study highlights the potential
value of using the insights of those with practical experi-
ence of alternative consent pathways to develop and offer
staff appropriate training and support.
When considering the generalizability and broader ap-
plicability of our findings, it should also be taken into
consideration that our research cohered around one
trial. It is possible that some of the issues and concerns
highlighted by the staff we interviewed might be height-
ened in, or restricted to, peripartum trials, such as
GOT-IT because obstetrics is one of the most litigious
specialities. Staffs’ concerns about litigation as a result
of adverse events occurring during normal clinical
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practice might therefore have influenced their views
about gaining consent from women to a clinical trial
where the perceived risk and benefits of trial participa-
tion are less clear. Furthermore, many women are given
a potent analgesia during labour and staff may have
been uncertain whether this might have affected their
ability to understand the trial and implications for
potential participation. In addition, as reported previ-
ously [25], GOT-IT involved investigation of what staff
considered a familiar, relatively low risk and benign drug.
Consequently, recruitment to the trial was regarded as
having been relatively unproblematic and uncontroversial.
We would therefore recommend that further research be
undertaken as part of the other trials offering verbal con-
sent at the time of enrolment, including those involving
“more risky” or unfamiliar interventions. The potential
value of undertaking further research as part of peripar-
tum trials delivered in other countries, where concerns
about patient autonomy and litigation may be different,
could also be considered.
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